KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Goodwill (2016 - 2025)

Historic Goodwill for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Vertex Pharmaceuticals' Goodwill changed 0.0% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.1 billion for FY2024, which is 109.09% down from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Goodwill of $1.1 billion as of Q3 2025, which was down 0.0% from $1.1 billion recorded in Q2 2025.
  • Vertex Pharmaceuticals' Goodwill's 5-year high stood at $1.1 billion during Q4 2022, with a 5-year trough of $1.0 billion in Q1 2021.
  • In the last 5 years, Vertex Pharmaceuticals' Goodwill had a median value of $1.1 billion in 2023 and averaged $1.1 billion.
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Goodwill surged by 975.85% in 2022, and later crashed by 109.09% in 2024.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Goodwill stood at $1.0 billion in 2021, then increased by 9.76% to $1.1 billion in 2022, then changed by 0.0% to $1.1 billion in 2023, then decreased by 1.09% to $1.1 billion in 2024, then changed by 0.0% to $1.1 billion in 2025.
  • Its Goodwill was $1.1 billion in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.1 billion in Q1 2025.